Available to mentor
-
PhDCornell University, Ithaca, 2002
-
BSCornell University, Ithaca, 1997
-
Center MemberRogel Cancer Center
-
Center MemberCenter for Computational Medicine and Bioinformatics
"...it would appear to be a pointless and doubtful exercise to examine and disentangle the apparently random appearing bacteria in normal feces and the intestinal tract, a situation that seems controlled by a thousand coincidences... Yet I have nevertheless devoted myself now for a year virtually exclusively to this special study, it was with the conviction that the accurate knowledge of these conditions is essential, for the understanding of not only the physiology of digestion..., but also the pathology and therapy of microbial intestinal diseases."
--Theodor Escherich (1888)
Nearly 130 years later, our research group shares the dedication of Theodor Escherich as we try to understand the role of the gut microbiota in Clostridium difficile infections and the progression of colorectal cancer. Since Escherich found the causative agent for diarrhea, what we now call E. coli, a lot has happened in science. We now have a far better understanding of microbiology, molecular biology, ecology, evolutionary theory, and statistics. Our research group is dedicated to integrating across disciplines to advance our knowledge of the role of the microbiome in human health. Human microbiome research is experiencing an amazing period of growth and we are helping to lead that effort.
Schloss Lab
-
Afiaz A, Ivanov AA, Chamberlin J, Hanauer D, Savonen CL, Goldman MJ, Morgan M, Reich M, Getka A, Holmes A, Pati S, Knight D, Boutros PC, Bakas S, Caporaso JG, Del Fiol G, Hochheiser H, Haas B, Schloss PD, Eddy JA, Albrecht J, Fedorov A, Waldron L, Hoffman AM, Bradshaw RL, Leek JT, Wright C. Bioinformatics, 2024 Aug 2; 40 (8):Journal ArticleBest practices to evaluate the impact of biomedical research software-metric collection beyond citations.
DOI:10.1093/bioinformatics/btae469 PMID: 39067017 -
Schloss P. 2024 Apr;PresentationThe Team, The Team, The Team
-
Rifkin SB, Sze MA, Tuck K, Koeppe E, Stoffel EM, Schloss PD. J Gastrointest Cancer, 2024 Mar; 55 (1): 207 - 218.Journal ArticleGut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls.
DOI:10.1007/s12029-023-00925-4 PMID: 37310549 -
Schloss PD. mSphere, 2024 Feb 28; 9 (2): e0035423Journal ArticleRarefaction is currently the best approach to control for uneven sequencing effort in amplicon sequence analyses.
DOI:10.1128/msphere.00354-23 PMID: 38251877 -
Schloss PD. mSphere, 2024 Jan 30; 9 (1): e0035523Journal ArticleWaste not, want not: revisiting the analysis that called into question the practice of rarefaction.
DOI:10.1128/msphere.00355-23 PMID: 38054712 -
Schloss PD, Cuomo CA. Microbiol Spectr, 2023 Dec 12; 11 (6): e0349623Journal ArticleMore evidence of Impact Factor Mania.
DOI:10.1128/spectrum.03496-23 PMID: 37909768 -
Armour CR, Sovacool KL, Close WL, Topçuoğlu BD, Wiens J, Schloss PD. mSphere, 2023 Oct 24; 8 (5): e0033623Journal ArticleMachine learning classification by fitting amplicon sequences to existing OTUs.
DOI:10.1128/msphere.00336-23 PMID: 37615431 -
Schloss P. 2023 bioRxiv,PreprintWaste not, want not: Revisiting the analysis that called into question the practice of rarefaction
DOI:10.1101/2023.06.23.546312